Clinical Trials Directory

Trials / Completed

CompletedNCT05963204

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen

A Randomized, Double-blinded, Split-face, Comparative Study to Evaluate the Synergistic Effects for Improving the Aging Midface When Pairing a Biostimulator with a Skincare Regimen

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography

Detailed description

This is a randomized, double-blinded, split-face, comparative study. This study is designed to enroll and randomize approximately 20 subjects. All subjects are to have midface volume loss and contour deficiency and facial photodamage. Eligible subjects are randomized to receive study skincare products for pre-conditioning, 2 weeks before Baseline. All subjects receive biostimulator treatment at the midface by the Treating Investigator at Baseline. The method of injection is at the discretion of the Treating Investigator. A sufficient amount of product is injected to achieve optimal correction of the midface, in the opinion of the Treating Investigator. At the 6-week visit, after all study procedures for the visit are completed, treated subjects received a second biostimulator treatment to achieve optimal aesthetic improvement. At the 12-week and 18-week visits, similar study procedures are performed.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTSculptra and Alastin Restorative Skin ComplexBiostimulator and cosmetics
COMBINATION_PRODUCTSculptra and CeraVe Daily Moisturizing LotionBiostimulator and cosmetics

Timeline

Start date
2023-07-07
Primary completion
2024-03-19
Completion
2024-03-19
First posted
2023-07-27
Last updated
2024-10-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05963204. Inclusion in this directory is not an endorsement.